Starting at: 16 weeks
Frequency: Weekly to 36 weeks
Purpose: To reduce the risk of preterm delivery in women with a history of spontaneous preterm delivery.

Weekly injections of 17 alpha-hydroxyprogesterone caproate (known as 17P or P17) have been shown to reduce the risk of preterm delivery. Members of the PROM list have had success with preventing preterm labor and controlling “irritable uterus” syndrome by using P17 shots in their PAP pregnancies.

Discuss with your health care practitioner whether weekly P17 shots are right for you, and at what point in your pregnancy you should begin the shots. Also, check with your insurance to see whether this therapy is covered.

For more information about P17 shots, see this website:www.hydroxyprogesterone.com.

Continue >>